Global Exenatide Market Research Report 2025

Exenatide Market

Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.

Exenatide is a medication used in the treatment of type 2 diabetes mellitus. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. There are several factors that contribute to the market drive for exenatide: Exenatide has been shown to effectively lower blood glucose levels, improve glycemic control, and reduce HbA1c levels in patients with type 2 diabetes. It is also associated with weight loss, which is beneficial for overweight or obese patients. The medication has a positive impact on cardiovascular health by reducing the risk of myocardial infarction and stroke. As a GLP-1 agonist, exenatide mimics the physiological effects of incretin hormones, which are released in response to food ingestion. It enhances the body"s natural response to food by increasing insulin secretion, suppressing glucagon secretion, and delaying gastric emptying. The medication"s unique mechanism of action sets it apart from other diabetes medications, and it is considered a valuable treatment option for patients who are not achieving glycemic control with other medications. Exenatide is administered by subcutaneous injection, once or twice daily, and can be self-administered by patients. The medication"s convenient dosing schedule and ease of use make it a popular choice among patients and healthcare providers. The prevalence of diabetes is increasing globally, and there is a significant unmet need for effective and well-tolerated treatment options. Exenatide is gaining market acceptance as a result of its proven efficacy, safety, and convenience. The medication is approved for use in several countries, including the United States, Europe, and Japan. Exenatide is protected by patents, which contribute to the medication"s market drive by limiting competition and ensuring market exclusivity. The medication"s patent protection has helped to maintain its market position and secure its profitability for the pharmaceutical companies that manufacture it.

This report aims to provide a comprehensive presentation of the global market for Exenatide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exenatide.

The Exenatide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exenatide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Exenatide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Exenatide Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Exenatide Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Extended-release injectable suspension

1.2.3 Fast release injectable suspension

1.3 Market by Application

1.3.1 Global Exenatide Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Drug store

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Exenatide Market Perspective (2020-2031)

2.2 Global Exenatide Growth Trends by Region

2.2.1 Global Exenatide Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Exenatide Historic Market Size by Region (2020-2025)

2.2.3 Exenatide Forecasted Market Size by Region (2026-2031)

2.3 Exenatide Market Dynamics

2.3.1 Exenatide Industry Trends

2.3.2 Exenatide Market Drivers

2.3.3 Exenatide Market Challenges

2.3.4 Exenatide Market Restraints

3.1 Global Top Exenatide Players by Revenue

3.1.1 Global Top Exenatide Players by Revenue (2020-2025)

3.1.2 Global Exenatide Revenue Market Share by Players (2020-2025)

3.2 Global Exenatide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Exenatide Revenue

3.4 Global Exenatide Market Concentration Ratio

3.4.1 Global Exenatide Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Exenatide Revenue in 2024

3.5 Global Key Players of Exenatide Head office and Area Served

3.6 Global Key Players of Exenatide, Product and Application

3.7 Global Key Players of Exenatide, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Exenatide Historic Market Size by Type (2020-2025)

4.2 Global Exenatide Forecasted Market Size by Type (2026-2031)

5.1 Global Exenatide Historic Market Size by Application (2020-2025)

5.2 Global Exenatide Forecasted Market Size by Application (2026-2031)

6.1 North America Exenatide Market Size (2020-2031)

6.2 North America Exenatide Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Exenatide Market Size by Country (2020-2025)

6.4 North America Exenatide Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7.1 Europe Exenatide Market Size (2020-2031)

7.2 Europe Exenatide Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Exenatide Market Size by Country (2020-2025)

7.4 Europe Exenatide Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Exenatide Market Size (2020-2031)

8.2 Asia-Pacific Exenatide Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Exenatide Market Size by Region (2020-2025)

8.4 Asia-Pacific Exenatide Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Exenatide Market Size (2020-2031)

9.2 Latin America Exenatide Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Exenatide Market Size by Country (2020-2025)

9.4 Latin America Exenatide Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Exenatide Market Size (2020-2031)

10.2 Middle East & Africa Exenatide Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Exenatide Market Size by Country (2020-2025)

10.4 Middle East & Africa Exenatide Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Exenatide Introduction

11.1.4 AstraZeneca Revenue in Exenatide Business (2020-2025)

11.1.5 AstraZeneca Recent Development

11.2 Byetta

11.2.1 Byetta Company Details

11.2.2 Byetta Business Overview

11.2.3 Byetta Exenatide Introduction

11.2.4 Byetta Revenue in Exenatide Business (2020-2025)

11.2.5 Byetta Recent Development

11.3 guangzhou tosun pharmaceutical co. ltd.

11.3.1 guangzhou tosun pharmaceutical co. ltd. Company Details

11.3.2 guangzhou tosun pharmaceutical co. ltd. Business Overview

11.3.3 guangzhou tosun pharmaceutical co. ltd. Exenatide Introduction

11.3.4 guangzhou tosun pharmaceutical co. ltd. Revenue in Exenatide Business (2020-2025)

11.3.5 guangzhou tosun pharmaceutical co. ltd. Recent Development

11.4 Fierce Pharma

11.4.1 Fierce Pharma Company Details

11.4.2 Fierce Pharma Business Overview

11.4.3 Fierce Pharma Exenatide Introduction

11.4.4 Fierce Pharma Revenue in Exenatide Business (2020-2025)

11.4.5 Fierce Pharma Recent Development

11.5 MIMS Hong Kong

11.5.1 MIMS Hong Kong Company Details

11.5.2 MIMS Hong Kong Business Overview

11.5.3 MIMS Hong Kong Exenatide Introduction

11.5.4 MIMS Hong Kong Revenue in Exenatide Business (2020-2025)

11.5.5 MIMS Hong Kong Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Exenatide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

 Table 2. Key Players of Extended-release injectable suspension

 Table 3. Key Players of Fast release injectable suspension

 Table 4. Global Exenatide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

 Table 5. Global Exenatide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 6. Global Exenatide Market Size by Region (2020-2025) & (US$ Million)

 Table 7. Global Exenatide Market Share by Region (2020-2025)

 Table 8. Global Exenatide Forecasted Market Size by Region (2026-2031) & (US$ Million)

 Table 9. Global Exenatide Market Share by Region (2026-2031)

 Table 10. Exenatide Market Trends

 Table 11. Exenatide Market Drivers

 Table 12. Exenatide Market Challenges

 Table 13. Exenatide Market Restraints

 Table 14. Global Exenatide Revenue by Players (2020-2025) & (US$ Million)

 Table 15. Global Exenatide Market Share by Players (2020-2025)

 Table 16. Global Top Exenatide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exenatide as of 2024)

 Table 17. Ranking of Global Top Exenatide Companies by Revenue (US$ Million) in 2024

 Table 18. Global 5 Largest Players Market Share by Exenatide Revenue (CR5 and HHI) & (2020-2025)

 Table 19. Global Key Players of Exenatide, Headquarters and Area Served

 Table 20. Global Key Players of Exenatide, Product and Application

 Table 21. Global Key Players of Exenatide, Date of Enter into This Industry

 Table 22. Mergers & Acquisitions, Expansion Plans

 Table 23. Global Exenatide Market Size by Type (2020-2025) & (US$ Million)

 Table 24. Global Exenatide Revenue Market Share by Type (2020-2025)

 Table 25. Global Exenatide Forecasted Market Size by Type (2026-2031) & (US$ Million)

 Table 26. Global Exenatide Revenue Market Share by Type (2026-2031)

 Table 27. Global Exenatide Market Size by Application (2020-2025) & (US$ Million)

 Table 28. Global Exenatide Revenue Market Share by Application (2020-2025)

 Table 29. Global Exenatide Forecasted Market Size by Application (2026-2031) & (US$ Million)

 Table 30. Global Exenatide Revenue Market Share by Application (2026-2031)

 Table 31. North America Exenatide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 32. North America Exenatide Market Size by Country (2020-2025) & (US$ Million)

 Table 33. North America Exenatide Market Size by Country (2026-2031) & (US$ Million)

 Table 34. Europe Exenatide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 35. Europe Exenatide Market Size by Country (2020-2025) & (US$ Million)

 Table 36. Europe Exenatide Market Size by Country (2026-2031) & (US$ Million)

 Table 37. Asia-Pacific Exenatide Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 38. Asia-Pacific Exenatide Market Size by Region (2020-2025) & (US$ Million)

 Table 39. Asia-Pacific Exenatide Market Size by Region (2026-2031) & (US$ Million)

 Table 40. Latin America Exenatide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 41. Latin America Exenatide Market Size by Country (2020-2025) & (US$ Million)

 Table 42. Latin America Exenatide Market Size by Country (2026-2031) & (US$ Million)

 Table 43. Middle East & Africa Exenatide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 44. Middle East & Africa Exenatide Market Size by Country (2020-2025) & (US$ Million)

 Table 45. Middle East & Africa Exenatide Market Size by Country (2026-2031) & (US$ Million)

 Table 46. AstraZeneca Company Details

 Table 47. AstraZeneca Business Overview

 Table 48. AstraZeneca Exenatide Product

 Table 49. AstraZeneca Revenue in Exenatide Business (2020-2025) & (US$ Million)

 Table 50. AstraZeneca Recent Development

 Table 51. Byetta Company Details

 Table 52. Byetta Business Overview

 Table 53. Byetta Exenatide Product

 Table 54. Byetta Revenue in Exenatide Business (2020-2025) & (US$ Million)

 Table 55. Byetta Recent Development

 Table 56. guangzhou tosun pharmaceutical co. ltd. Company Details

 Table 57. guangzhou tosun pharmaceutical co. ltd. Business Overview

 Table 58. guangzhou tosun pharmaceutical co. ltd. Exenatide Product

 Table 59. guangzhou tosun pharmaceutical co. ltd. Revenue in Exenatide Business (2020-2025) & (US$ Million)

 Table 60. guangzhou tosun pharmaceutical co. ltd. Recent Development

 Table 61. Fierce Pharma Company Details

 Table 62. Fierce Pharma Business Overview

 Table 63. Fierce Pharma Exenatide Product

 Table 64. Fierce Pharma Revenue in Exenatide Business (2020-2025) & (US$ Million)

 Table 65. Fierce Pharma Recent Development

 Table 66. MIMS Hong Kong Company Details

 Table 67. MIMS Hong Kong Business Overview

 Table 68. MIMS Hong Kong Exenatide Product

 Table 69. MIMS Hong Kong Revenue in Exenatide Business (2020-2025) & (US$ Million)

 Table 70. MIMS Hong Kong Recent Development

 Table 71. Research Programs/Design for This Report

 Table 72. Key Data Information from Secondary Sources

 Table 73. Key Data Information from Primary Sources

 Table 74. Authors List of This Report

List of Figures

 Figure 1. Exenatide Picture

 Figure 2. Global Exenatide Market Size Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Exenatide Market Share by Type: 2024 VS 2031

 Figure 4. Extended-release injectable suspension Features

 Figure 5. Fast release injectable suspension Features

 Figure 6. Global Exenatide Market Size by Application (2020-2031) & (US$ Million)

 Figure 7. Global Exenatide Market Share by Application: 2024 VS 2031

 Figure 8. Hospital Case Studies

 Figure 9. Drug store Case Studies

 Figure 10. Exenatide Report Years Considered

 Figure 11. Global Exenatide Market Size (US$ Million), Year-over-Year: 2020-2031

 Figure 12. Global Exenatide Market Size, (US$ Million), 2020 VS 2024 VS 2031

 Figure 13. Global Exenatide Market Share by Region: 2024 VS 2031

 Figure 14. Global Exenatide Market Share by Players in 2024

 Figure 15. Global Top Exenatide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exenatide as of 2024)

 Figure 16. The Top 10 and 5 Players Market Share by Exenatide Revenue in 2024

 Figure 17. North America Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 18. North America Exenatide Market Share by Country (2020-2031)

 Figure 19. United States Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 20. Canada Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 21. Europe Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 22. Europe Exenatide Market Share by Country (2020-2031)

 Figure 23. Germany Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 24. France Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 25. U.K. Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 26. Italy Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 27. Russia Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 28. Nordic Countries Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 29. Asia-Pacific Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 30. Asia-Pacific Exenatide Market Share by Region (2020-2031)

 Figure 31. China Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 32. Japan Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 33. South Korea Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 34. Southeast Asia Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 35. India Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 36. Australia Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 37. Latin America Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 38. Latin America Exenatide Market Share by Country (2020-2031)

 Figure 39. Mexico Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 40. Brazil Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 41. Middle East & Africa Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 42. Middle East & Africa Exenatide Market Share by Country (2020-2031)

 Figure 43. Turkey Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 44. Saudi Arabia Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 45. UAE Exenatide Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 46. AstraZeneca Revenue Growth Rate in Exenatide Business (2020-2025)

 Figure 47. Byetta Revenue Growth Rate in Exenatide Business (2020-2025)

 Figure 48. guangzhou tosun pharmaceutical co. ltd. Revenue Growth Rate in Exenatide Business (2020-2025)

 Figure 49. Fierce Pharma Revenue Growth Rate in Exenatide Business (2020-2025)

 Figure 50. MIMS Hong Kong Revenue Growth Rate in Exenatide Business (2020-2025)

 Figure 51. Bottom-up and Top-down Approaches for This Report

 Figure 52. Data Triangulation

 Figure 53. Key Executives Interviewed